Can psychedelics overcome the complex legal challenges to provide wider access to their benefits?

Psychedelics hold immense promise for disrupting the consumer wellness space, and present a potentially lucrative opportunity for investors. But before they can fully capitalize on this potential, psychedelic brands will need to navigate the significant legal hurdles before them. Brett Gelbord sits down with Evan Eneman, founder and CEO of The Sands Lane Foundation, to explore the benefits of psychedelics, the investment opportunities they offer, and the complex legal framework that could impact their growth and success.

To hear more episodes, be sure to subscribe to Dykema’s YouTube channel, the Cannabis Law Blog, or by searching “A Higher Law” wherever you get your podcasts.